Your browser doesn't support javascript.
loading
Novel anti-GARP antibody DS-1055a augments anti-tumor immunity by depleting highly suppressive GARP+ regulatory T cells.
Satoh, Kazuki; Kobayashi, Yoichi; Fujimaki, Kaori; Hayashi, Shinko; Ishida, Saori; Sugiyama, Daisuke; Sato, Takahiko; Lim, Kyungtaek; Miyamoto, Megumi; Kozuma, Shiho; Kadokura, Michinori; Wakita, Kenichi; Hata, Masato; Hirahara, Kazuki; Amano, Masato; Watanabe, Ichiro; Okamoto, Atsushi; Tuettenberg, Andrea; Jonuleit, Helmut; Tanemura, Atsushi; Maruyama, Shoichi; Agatsuma, Toshinori; Wada, Teiji; Nishikawa, Hiroyoshi.
Affiliation
  • Satoh K; Early Clinical Development Department, Daiichi Sankyo Co., Ltd., Tokyo 140-8710, Japan.
  • Kobayashi Y; Department of Immunology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
  • Fujimaki K; Department of Nephrology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
  • Hayashi S; Department of Immunology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
  • Ishida S; Oncology Research Laboratories I, Daiichi Sankyo Co., Ltd., Tokyo 140-8710, Japan.
  • Sugiyama D; Oncology Research Laboratories I, Daiichi Sankyo Co., Ltd., Tokyo 140-8710, Japan.
  • Sato T; Department of Immunology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
  • Lim K; Department of Immunology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
  • Miyamoto M; Translational Research Department, Daiichi Sankyo RD Novare Co., Ltd., Tokyo 134-8630, Japan.
  • Kozuma S; Oncology Research Laboratories I, Daiichi Sankyo Co., Ltd., Tokyo 140-8710, Japan.
  • Kadokura M; Translational Science Department I, Daiichi Sankyo Co., Ltd., Tokyo 140-8710, Japan.
  • Wakita K; Modality Research Laboratories, Daiichi Sankyo Co., Ltd., Tokyo 140-8710, Japan.
  • Hata M; Translational Science Department I, Daiichi Sankyo Co., Ltd., Tokyo 140-8710, Japan.
  • Hirahara K; Oncology Research Laboratories I, Daiichi Sankyo Co., Ltd., Tokyo 140-8710, Japan.
  • Amano M; Biologics Planning Department, Daiichi Sankyo Co., Ltd., Gunma 370-0503, Japan.
  • Watanabe I; Modality Research Laboratories, Daiichi Sankyo Co., Ltd., Tokyo 140-8710, Japan.
  • Okamoto A; Biological Research Department, Daiichi Sankyo RD Novare Co., Ltd., Tokyo 134-8630, Japan.
  • Tuettenberg A; Translational Research Department, Daiichi Sankyo RD Novare Co., Ltd., Tokyo 134-8630, Japan.
  • Jonuleit H; Department of Dermatology, University Medical Center of the Johannes Gutenberg-University, Mainz 55131, Germany.
  • Tanemura A; Department of Dermatology, University Medical Center of the Johannes Gutenberg-University, Mainz 55131, Germany.
  • Maruyama S; Department of Dermatology, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan.
  • Agatsuma T; Department of Nephrology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
  • Wada T; Oncology Research Laboratories I, Daiichi Sankyo Co., Ltd., Tokyo 140-8710, Japan.
  • Nishikawa H; Oncology Research Laboratories I, Daiichi Sankyo Co., Ltd., Tokyo 140-8710, Japan.
Int Immunol ; 33(8): 435-446, 2021 07 23.
Article in En | MEDLINE | ID: mdl-34235533
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: T-Lymphocytes, Regulatory / Membrane Proteins / Antibodies, Monoclonal / Neoplasms Limits: Animals / Female / Humans Language: En Journal: Int Immunol Journal subject: ALERGIA E IMUNOLOGIA Year: 2021 Type: Article Affiliation country: Japan
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: T-Lymphocytes, Regulatory / Membrane Proteins / Antibodies, Monoclonal / Neoplasms Limits: Animals / Female / Humans Language: En Journal: Int Immunol Journal subject: ALERGIA E IMUNOLOGIA Year: 2021 Type: Article Affiliation country: Japan